Suppr超能文献

脂质在肿瘤对光动力疗法的反应中的参与及其用于治疗获益的开发利用。

Participation of lipids in the tumor response to photodynamic therapy and its exploitation for therapeutic gain.

作者信息

Korbelik Mladen, Heger Michal, Girotti Albert W

机构信息

Department of Integrative Oncology, BC Cancer, Vancouver, BC, Canada.

Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics, Department of Pharmaceutics, College of Medicine, Jiaxing University, Jiaxing, Zhejiang, P. R. China; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Membrane Biochemistry and Biophysics, Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, the Netherlands.

出版信息

J Lipid Res. 2025 Feb;66(2):100729. doi: 10.1016/j.jlr.2024.100729. Epub 2024 Dec 14.

Abstract

Hydroperoxides of unsaturated membrane lipids (LOOHs) are the most abundant non-radical intermediates generated by photodynamic therapy (PDT) of soft tissues such as tumors and have far longer average lifetimes than singlet oxygen or oxygen radicals formed during initial photodynamic action. LOOH-initiated post-irradiation damage to remaining membrane lipids (chain peroxidation) or to membrane-associated proteins remains largely unrecognized. Such after-light processes could occur during clinical oncological PDT, but this is not well-perceived by practitioners of this therapy. In general, the pivotal influence of lipids in tumor responses to PDT needs to be better appreciated. Of related importance is the fact that most malignant tumors have dramatically different lipid metabolism compared with healthy tissues, and this too is often ignored. The response of tumors to PDT appears especially vulnerable to manipulations within the tumor lipid microenvironment. This can be exploited for therapeutic gain with PDT, as exemplified here by the combined treatment with the antitumor lipid edelfosine.

摘要

不饱和膜脂的氢过氧化物(LOOHs)是光动力疗法(PDT)治疗肿瘤等软组织时产生的最丰富的非自由基中间体,其平均寿命比初始光动力作用过程中形成的单线态氧或氧自由基长得多。LOOH引发的对剩余膜脂(链过氧化)或膜相关蛋白的照射后损伤在很大程度上仍未被认识到。这种光后过程可能发生在临床肿瘤学PDT期间,但该疗法的从业者对此并未充分认识。一般来说,脂质在肿瘤对PDT反应中的关键影响需要得到更好的认识。同样重要的是,大多数恶性肿瘤与健康组织相比具有显著不同的脂质代谢,而这一点也常常被忽视。肿瘤对PDT的反应似乎特别容易受到肿瘤脂质微环境内操作的影响。这可以通过PDT用于治疗获益,此处以与抗肿瘤脂质依地福新联合治疗为例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f76/11911859/e73396213784/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验